Slide 1: ppeit |
Vy ppeit |
Slide 2: Disclaimer
DISCLAIMER This pres entat ion als o conta ins estimat es an d oth er statistica l dat a mad e by i nd epe nd ent pa rties a nd b y the C omp any re lati ng to mark et size the co nce ntratio n of o ur voti ng po wer a s a re sult of our dua l cl ass struct ure; o ur status as a for eig n pr ivate i
Slide 3: Our vision is to transform the global beauty & wellness market
OUR VISION IS TO TRANSFORM THE GLOBAL BEAUTY & WELLNESS MARKET THROUGH ISRAELI TECHNOLOGY & ENTREPRENEURIAL THINKING FOR THE BENEFIT OF CONSUMERS ALL OVER THE WORLD. 3
Slide 4: Our platform: powerhouse brands with shared technology and shared data
OUR PLATFORM: POWERHOUSE BRANDS WITH SHARED TECHNOLOGY + SHARE DATA 4
Slide 5: Large global TAM with deep moats
LARGE GLOBAL TAM WITH DEEP MOATS $600B+ Total Beauty & Wellness1 Skin Care Color Cosm etics GLOBAL ADDRESSABLE MARKET ODDITY VS LEGACY MODELS Source: Euromonitor 2022 5 Note: 1. Defined as the global beauty and personal care and dietary supplements market, per Euromonitor, in 2022. Includes color co
Slide 6: $ODD financial highlights
$ODD FINANCIAL HIGHLIGHTS $509M $107M $168M Net revenue, Adjusted EBITDA1, Cash, cash equivalents, FY 23 FY 23 & investments, Q423 +57% 21% $85M YoY net revenue Adjusted EBITDA2 Free cash flow3, growth, FY 23 margin, FY 23 FY 23 Note: 6 1. Adjusted EBITDA is a supplemental measure of our performance
Slide 7: A rare combination of scale + growth + profitability
A RARE COMBINATION OF SCALE + GROWTH + PROFITABILITY +57% +46% NET REVENUE GROWTH 2 $509M $325M $223M NET REVENUE $107M ADJUSTED EBITDA1 $27M $39M FY21 FY22 FY23 Note: 1. Adjusted EBITDA is a supplemental measure of our performance that is not required by, or presented in accordance with, GAAP. Adju
Slide 8: Q4 2023 and FY 2023 results exceeded guidance
Q4 2023 AND FY 2023 RESULTS EXCEEDED GUIDANCE Q4 2023 FY 2023 GUIDANCE GUIDANCE ACTUAL (issued November) ACTUAL (issued November) NET REVENUE 44.1% 22.0 to 26.0% 56.7% 52.0 to 53.0% GROWTH GROSS MARGIN 69.4% 66.0% 70.4% 70.0% ADJUSTED EBITDA 16.8% 15.5 to 16.5% 21.1% 21.0% MARGIN1 2 ADJUSTED $0.17 $
Slide 9: Introducing Q1 2024 and FY 2024 outlook
INTRODUCING Q1 2024 AND FY 2024 OUTLOOK Q1 2024 FY 2024 NET REVENUE 23 to 25%3 / 22 to 24%4 / GROWTH / $ $204 to 207 million $620 to 630 million GROSS MARGIN 71.0% 70.5% ADJUSTED $43 to 45 million $136 to 140 million EBITDA1 ADJUSTED $0.47 to 0.50 $1.49 to 1.54 DILUTED EPS2 Note: 1. Adjusted EBITDA
Slide 10: Q4 2023 highlights
Q4 2023 HIGHLIGHTS In millions Q4 2023 vs Q4 2022 Net Revenue $97.2 +44% Gross Margin 69.4% +400 bps Adjusted EBITDA1 $16.3 +520% Adjusted EBITDA margin2 16.8% +1290 bps Adjusted Diluted EPS3 $0.17 nm Note: 1. Adjusted EBITDA is a supplemental measure of our performance that is not required by, or p
Slide 11: FY 2023 highlights
FY 2023 HIGHLIGHTS In millions FY 2023 vs FY 2022 Net Revenue $508.7 +57% Gross Margin 70.4% +320 bps Adjusted EBITDA1 $107.3 +172% Adjusted EBITDA margin2 21.1% +900 bps Adjusted Diluted EPS3 $1.31 nm Free cash flow4 $85.4 +133% Note: 1. Adjusted EBITDA is a supplemental measure of our performance
Slide 12: Appendix
APPENDIX 12
Slide 13: Reconciliation of net income to Adjusted EBITDA
RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA Three Months Ended Year Ended December 30, December 31, ($ in millions) 2022 2023 2021 2022 2023 Net Income (0.7) $5.1 $13.9 $21.7 $58.5 % Margin -1% 5% 6% 7% 12% Adjusted to exclude the following: Financial Expenses (Income), Net 0.3 (1.4) 0.9 (1.2) (
Slide 14: Reconciliation of net cash from operating activities to free cash flow
Reconciliation of Net Cash from Operating Activities to Free Cash Flow Year Ended December 31, ($ in thousands) 2021 2022 2023 Net Cash From Operating Activities $ 10 $ 39 $87 Purchase of PP&E (2) (2) (2) Free Cash Flow1 $8 $ 37 $85 Free Cash Flow Conversion2 56 % 169 % 146 % Note: 1. Free Cash Flow